Xingyu Jiang

Dr. Xingyu Jiang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJing Gao
Jing Gao
XJXingyu Jiang
Xingyu Jiang
SLShumin Lei
Shumin Lei
WCWenhao Cheng
Wenhao Cheng
YLYi Lai
Yi Lai
ZXZhiai Xu
Zhiai Xu
The antitumor performance of PROteolysis-TArgeting Chimeras (PROTACs) is limited by its insufficient tumor specificity and poor pharmacokinetics. These disadvantages are further compounded by tumor heterogeneity, especially the presence of cancer stem-like cells, which drive tumor growth and relapse. Herein, we design a region-confined PROTAC nanoplatform that integrates both reactive oxygen species (ROS)-activatable and hypoxia-responsive PROTAC prodrugs for the precise manipulation of bromodomain and extraterminal protein 4 expression and tumor eradication. These PROTAC nanoparticles selectively accumulate within and penetrate deep into tumors via response to matrix metalloproteinase-2. Photoactivity is then reactivated in response to the acidic intracellular milieu and the PROTAC is discharged due to the ROS generated via photodynamic therapy specifically within the normoxic microenvironment. Moreover, the latent hypoxia-responsive PROTAC prodrug is restored in hypoxic cancer stem-like cells overexpressing nitroreductase. Here, we show the ability of region-confined PROTAC nanoplatform to effectively degrade BRD4 in both normoxic and hypoxic environments, markedly hindering tumor progression in breast and head-neck tumor models.


30 July 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
JSJinyu Sun
Jinyu Sun
XJXingyu Jiang
Xingyu Jiang
ZLZheng Li
Zheng Li
YSYang Shen
Yang Shen
Background: This study examines the association between dietary patterns and survival outcomes in patients with cardiovascular disease (CVD).Methods: A total of 9,101 adults with CVD from the 2005–2018 National Health and Nutrition Examination Survey were included. Dietary patterns were evaluated using five indices: the Alternative Healthy Eating Index (AHEI), Dietary Approaches to Stop Hypertension (DASH), Dietary Inflammatory Index (DII), Healthy Eating Index-2020 (HEI-2020), and the Alternative Mediterranean Diet Score (aMED). Associations between dietary indices and all-cause mortality were assessed using Kaplan-Meier survival analysis, weighted Cox regression models, and restricted cubic spline analyses. Predictive performance was evaluated using time-dependent receiver operating characteristic (Time-ROC) curves.Results: After a median follow-up of 7 years, 1,225 deaths were recorded. Survivors had higher AHEI, DASH scores, and lower DII scores. Kaplan-Meier analysis suggested better survival outcomes associated with higher adherence to healthier dietary patterns (AHEI, DASH, HEI-2020, aMED) and lower adherence to pro-inflammatory diets (DII). Weighted Cox regression revealed significant associations between higher scores on AHEI, DASH, HEI-2020, and aMED and reduced mortality risk (highest vs. lowest tertile HRs: 0.59, 0.73, 0.65, and 0.75, respectively; all P < 0.05). Conversely, higher DII scores were associated with increased mortality risk, with the highest tertile showing significantly elevated risk compared to the lowest tertile (HR = 1.58, 95% CI: 1.21–2.06; P < 0.001). Restricted cubic spline analyses identified a significant non-linear relationship between AHEI scores and mortality (P fornon–linearity = 0.036), while other indices exhibited linear associations. Time-ROC analysis indicated that dietary indices maintain relatively consistent predictive effectiveness for mortality risk over time.Conclusion: Improved healthy dietary patterns could potentially reduce mortality risk in CVD patients, underscoring the need for dietary quality enhancement in managing CVD.

6 October 2022 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
XJXingyu Jiang
Xingyu Jiang
QLQi Liang
Qi Liang
HXHuanhuan Xu
Huanhuan Xu
SGShouyong Gu
Shouyong Gu
LLLingxiang Liu
Lingxiang Liu
Aims. This paper aims to investigate the relationship of waist circumference (WC) with digestive tract cancer morbidity and mortality. Methods. Based on the data from a nationally representative US population survey, we summarized the prevalence of digestive tract cancer and all-cause mortality of cancer patients across WC quartiles. Adjusted logistic regression and restricted spline curve were used to analyze WC and the prevalence of digestive tract cancer. Moreover, Cox regression and the Kaplan-Meier curve were applied to investigate the association of WC with all-cause mortality. We also attempted to make a model to predict cancer happening. Results. This paper included a total of 34,041 participants, with digestive tract cancer observed in 265 (0.7) individuals. WC was positively associated with digestive tract cancer morbidity after full adjustment of covariates (OR: 1.72 and 95 CI: 1.41-2.10). Also, individuals in the highest WC group had a higher risk of digestive tract cancer (Q4, OR: 2.71 and 95 CI: 1.48-5.00). Moreover, no significant association was observed in upper digestive cancer, and WC was associated with a longer survival time once diagnosed (hazard ratio (HR): 0.50 and 95 CI: 0.28-0.92). Finally, the model we made proved to be effective. Conclusion. High WC is a risk factor for digestive tract cancer with or without adjusting for body mass index, especially those located in the lower digestive tract. However, once digestive tract cancer has been diagnosed, patients with higher WC showed better survival outcomes. Moreover, machine learning methods can be used to predict digestive tract cancer risk in the future.